Brief: Oncolytics Biotech Reports Q3 Loss Per Share C$0.16
11/11/2020 21:40
Nov 11 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH® REPORTS 2020 THIRD QUARTER DEVELOPMENT
HIGHLIGHTS AND FINANCIAL RESULTS
* Q3 LOSS PER SHARE C$0.16
* AS OF SEPTEMBER 30, 2020, COMPANY REPORTED $26.7 MILLION
IN CASH
AND CASH EQUIVALENTS
Source text for Eikon: ID:nCNW2wcsda
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer